Category Archives: Diseases

Prof. Lucien Abenhaim: There is an incredible challenge for the sustainability of health systems across the world

Prof. Lucien Abenhaim

LONDON, Dec-3-2017 — /EuropaWire/ — On December 5-6, 2017, 200 high-level experts from government, academia, biopharmaceutical developers and patient organisations convene in London (UK) to address the mounting challenge of accessibility and patient access to high-value, high-cost medical therapies.

The not-for-profit executive forum is organised by the London School of Hygiene and Tropical Medicine and analytica|LASER, a global research consultancy, to investigate topical questions around drug policy, global health systems sustainability and innovation funding through a combination of case studies, panel sessions, and roundtables. Delegations are registered from over 70 public and private organisations, including the World Health Organization, as well as health systems representatives from Belgium, England, Estonia, Croatia, France, Germany, Italy, Norway, Sweden, the United States and Wales. Multiple patient organisations support the meeting to ensure that the patient voice is reflected in all deliberations.

“Access to life-saving drugs is not a new challenge. The paradigm of accessibility was changed completely in the face of the deadly HIV epidemic. This time, however, accessibility concerns almost every domain of medicine such as cancer, auto-immune diseases and rare diseases. We must act now,” says Prof Peter Piot, Director of the London School of Hygiene & Tropical Medicine and former head of UNAIDS.

“There is an incredible challenge for the sustainability of health systems across the world”, says Prof. Lucien Abenhaim, London School of Hygiene & Tropical Medicine and Chairman of Analytica Laser. “It is critical that drug developers and health system engage on actionable proposals that address concerns around value, cost and overall access to innovation for the patients who need it. We are at an inflection point – the paradigms of the 1990’s can no longer guide us,” he adds.

The main plenary on December 6th features scheduled remarks by over a dozen authorities in the field, including Professor Baron Peter Piot (Director, London School of Hygiene & Tropical Medicine and former Head, UNAIDS), Dr. Olivier Brandicourt (Chief Executive Officer, Sanofi), Dr. Sarah Garner (World Health Organization), Prof. Dominique Le Guludec (President, French HAS), Sir Andrew Dillon (Chief Executive, National Institute for Health and Care Excellence UK) and Dr. Harold Paz (Chief Medical Officer, Aetna). The plenary is preceded by a scientific seminar on December 5th which gathers globally renowned academics to explore new frontiers on the methodology for the appraisal and valuation of high-value medicines.

Please contact the organisers for more information on the programming and media access, or refer to www.accessibility-symposium.org

SOURCE: EuropaWire

Multispectral Optoacoustic Tomography (MSOT) can now more reliably detect early stages of inflammation

GERMANY, Mar-30-2017 — /EPR HEALTHCARE NEWS/ — Ulcerative colitis and Crohn’s disease are the most common inflammatory bowel diseases (IBD). Globally, more than 4 million people suffer from recurring inflammation of the intestinal mucosa. To date, non-invasive methods have not been able to detect these forms of IBD reliably. Researchers at the University Hospital Erlangen (Germany) have now shown for the first time how Multispectral Optoacoustic Tomography (MSOT) can more reliably detect early stages of inflammation when compared with other non-invasive diagnostic methods. These results have recently been published in the New England Journal of Medicine.

Evaluating the inflammatory activity of the intestines early and accurately helps to prevent complications associated with IBD and guide an optimal therapy regime. Currently, doctors frequently rely on an invasive endoscopy procedure to assess the intestinal mucosa of patients with IBD. Additionally, non-invasive imaging methods are increasingly used in the clinic. For example, ultrasound allows clinicians to examine the structure, thickness and blood perfusion of the intestinal wall with changes in perfusion patterns indicating an onset of inflammation.

“With the MSOT procedure, we additionally use laser light, by which we can detect inflammation earlier than previously possible with ultrasound”, explains Prof. Dr. Maximilian Waldner, Professor at the University Hospital Erlangen. “The earlier we detect signs of an upcoming flare – i.e., a change in blood content – the quicker we can react and start a preventive treatment”. The MSOT technology was developed by iThera Medical in Munich, and was first used on IBD patients last year.

The researchers of the University Hospital Erlangen have recently published their results in the renowned New England Journal of Medicine. “We examined 108 patients with Crohn’s disease using the MSOT technology and compared the results to established non-invasive diagnostic procedures as well as endoscopy and histology”, says Prof. Waldner. “We were able to demonstrate that hemoglobin values in the tissue measured with MSOT indicate very accurately the inflammatory activity in the intestines. The method appears to be superior to other non-invasive procedures, as MSOT for the first time was able to detect even low levels of inflammation without having to perform endoscopy”.

Dr. Ferdinand Knieling, a physician at the University Hospital Erlangen, adds: “We are hoping that this principle can be applied to many applications and, in particular, also be used to enable safe evaluations of children and adolescents. With this new examination method, many of the currently invasive procedures might become obsolete.”

In optoacoustic imaging, the physician scans the intestines transabdominally through the skin, applying pulsed laser light in the near-infrared region. The energy of the light absorbed in tissue is converted into acoustic signals which are then acquired by an ultrasound detector. Christian Wiest, CEO of iThera Medical, comments: “MSOT is a new diagnostic imaging modality that can detect changes in tissue composition associated with a variety of diseases, without the use of contrast agents. The technology has already been applied in other clinical feasibility studies, e.g. for the detection of melanoma metastasis in sentinel lymph nodes or for the assessment of suspicious breast lesions”.

The results of the IBD study at the University Hospital Erlangen were published on March 30th 2017 in the New England Journal of Medicine (Volume 376, Issue 13, pg.1292-1294).

SOURCE: EuropaWire

TESTmyBRAIN opens its first center of Functional Neurology in Europe

GENEVA, 2016-Jun-8 — /EPR Healthcare News/ — TESTmyBRAIN (Switzerland) has opened its first center of Functional Neurology in Europe. This non-invasive therapy (no medication, no surgery) coming from the United States helps patients suffering from migraines, concussions, strokes, AD/HD, Parkinson disease, Alzheimer, … all disorders related to the brain and the central nervous system.

This innovative therapy combines several approaches and relies mainly over 3 decades of research on the eye-movements to diagnose and treat. Completely adopted and established in the United States, this therapy is almost unknown in Europe.

This is the reason why TESTmyBRAIN Switzerland is happy to bring the American experts to Europe to teach other doctors and to help patients differently with their pain.

SOURCE: EuropaWire

GenQual and R-Pharm collaborate to deliver predictive diagnostics for novel anti-IL-6 antibody for autoimmune diseases

Seattle, WA, San Francisco, CA and Moscow, Russia, 2016-May-25 — /EPR Healthcare News/ — R-Pharm and GenQual are pleased to announce a new collaboration focused on the development of novel predictive diagnostic tools in the area of Rheumatoid Arthritis and Autoimmune diseases.

The GenQual proprietary real-time PCR platform, when applied to the genes that are involved in the manifestation of several autoimmune diseases, allows us to detect and assess single nucleotide polymorphisms. Here, allelic determination is used as potential predictor of the treatment response by the novel anti-IL6 antibody, which is currently in development by R-Pharm.

GenQual Founder and CEO Jonathan Mirich said, “This partnership is exciting for GenQual as we advance in our goal to deliver predictive diagnostic tools for the treatment of autoimmune disorders. We are very excited about the possibilities in this space and are thankful to have quality partners in R-Pharm.”

R-Pharm CEO Vasily Ignatiev indicated the importance of the Autoimmune diseases as an area of the development and growth for R-Pharm, as well as the development of novel diagnostic tools aimed to increase the level of predictive response and efficiency of the upcoming treatment paradigm.

About GenQual
GenQual develops proprietary biomarker diagnostics for autoimmune and oncology indications.  Our personalized medicine products are designed to facilitate early disease detection and diagnosis, and to improve treatment approaches at the molecular level.  GenQual is a privately-held corporation based in Seattle, WA area, USA.

About R-Pharm
R-Pharm is a private Russian pharmaceutical company founded in 2001. It employs over 3,500 highly qualified specialists in 60+ branches. R-Pharm operates in Russia and CIS, USA, Germany, Japan, Turkey/MENA.

The company is involved in R&D, manufacturing (finished dosage forms, biotech and chemical APIs), marketing, sales and distribution of innovative pharmaceutical products in hospital/specialty care therapeutic areas.

R-Pharm collaborates with major international pharmaceutical companies and universities in the fields of drug discovery, development, clinical trials, manufacturing and commercialization.  The company operates several  GMP compliant manufacturing sites in Russia and Germany, research, BD/licensing and marketing affiliates in Japan, Germany, Turkey and US.

Marketed portfolio and pipeline features drugs used in oncology, hematology, autoimmune diseases, HIV, HCV, neurology, diabetes, cardiology, as well as antibiotics, contrast media and anesthesia agents.

Contact

R-Pharm
info@rpharm.ru
www.r-pharm.com/en/

 

GenQual

info@genqual.com
206.659.7825
www.genqual.com

 

Via EPR Network
More Healthcare press releases

Aging and Genes: Nutrition is Key

Each year, millions of Americans die of preventable, often chronic disease. This happens because people believe disease is caused by things they can’t control: inherited genes or aging. Neither is true. Health experts know that about 80% of health status is determined by daily choices and gene activity, not inherited genes or age.

Most genes are active day and night. They respond to many activities, especially nutrition. Other areas play a role, including, exercise, stress, weight and inflammation. In fact, it’s normal to replace about 1 billion cells every hour, and over time, that complex process of cell division can cause mutations and errors. What’s more, those risks are markedly increased by an unhealthy lifestyle.

A new, breakthrough article called, “Telomeres Genes and Aging” explores these critical issues and includes the latest research. The article includes critical “how to” tips to prevent chronic disease and improve longevity! It’s based on more than 50 credible source links, including numerous studies and expert sources. Some key findings are:

1. Nutrition and micro-nutrient intakes (vitamins, minerals, antioxidants) are key factors for gene activation and repair, including telomere length and longevity.

2. Other lifestyle areas contribute to gene health, including weight status, sleep, stress, activity, etc., and they all contribute to gene function, replication and repair.

3. Sirtuin proteins also help to activate or silence genes, especially those for metabolism, stress response, brain function, longevity, etc. Sirtuins are also enhanced by nutrient intake and harmed by nutrient deficiencies.

There is now enough research to show how to maximize gene health and replication, including telomere length, health and longevity. By making the right choices, gene health can be maximized, including the repair of mutations and genetic errors. Humans can largely control their health and destiny today!

Here is a link to the full article and source links:

http://www.endsicknessnow.com/telomeres-genes-and-aging

Contact: Steve Carney
steve@endsicknessnow.com
Twitter: @healthdietcoach

Via EPR Network
More Healthcare press releases

The End of Alzheimer’s? A revolutionary scientific advance to the cure

Interface Dynamics Control Corporation (IDCC) has completed the first phase of its decade-long Advanced Therapeutic Interventions Project, with the result that a new approach to arresting and curing Alzheimer’s disease and the other neurodegenerative diseases has been produced and verified. IDCC is now launching the Project’s second phase, which will validate the first phase findings.

Alzheimer’s disease is the sixth leading cause of death in the United States, with more than 5.1 million Americans currently affected. The direct cost of Alzheimer’s is greater than $200 billion annually, a number expected reach between $1.2 and $1.5 trillion by 2050. Indirect costs are substantial: more than 15 million caregivers delivered some 17.5 billion hours of unpaid care valued at more than $200 billion.

IDCC has discovered the mechanism of and means to control the protein misfolding, abnormal aggregation, and degradation processes associated with the degenerative and prion diseases. That mechanism is also implicated in the failure to clear toxic intracellular proteins and in the dysfunction of apoptotic (programmed cell death) pathways. It underlies the adverse functions of the neuroglia (glial cells), including microglia, which provide immune defense to the central nervous system (CNS) and maintain homeostasis and protection for neurons in the brain and the peripheral nervous system.

The process of neurodegeneration has not been understood previously, which has precluded the production of any arresting or curative procedures or drugs. The Project’s findings, however, should lead to the realization of a new class of curative procedures and pharmaceuticals which can be engaged to defeat the disease-initiating neurodegenerative insult, thereby introducing the possibility of preventing these devastating diseases. There are direct implications for the human cancers, but verification of those implications must await further experiments.

The first major activity under the Project’s second phase will be the production of a new class of active imaging system. That system will be utilized to demonstrate the activities and accessible control points of the process pathways which, when certain abnormal events occur, trigger the incipient causal mechanisms of disease. The Project is currently developing the staff and capitalization required for execution of its second phase.

About IDCC 
IDCC was founded thirteen years ago to produce definitive solutions to seemingly intractable problems of social and technological significance. It is privately held and maintains its projects and client identities in strict confidence unless and until information releases are authorized by competent authority.

Contact Details: Peter W. Atkinson
IDCC
4655 Logsdon Drive
Annandale, VA 22003-3564 USA
+1.703.879.7065
Peter@InterfaceDynamicsControl.com

Via EPR Network
More Healthcare press releases

20 cm Long Worm In The Human Eye, First Ever Recorded On Video

Can you believe that a 20 cm worm can house itself in the human eye? But one has to believe one’s eyes.

Here is the video clip of a 20 cm long worm being removed from a human eye through surgical procedure. It is the first time ever that such a long worm growing in the eye has been recorded. The video has evoked great interest among medical students as well as the general public.

http://www.indiavideo.org/health/loa-loa-worm-removing-surgery-8857.php 

Dr. Ashley Thomas Mulamoottil, the doctor who recorded this unique surgery says that this is the seventh worm that he has removed in the last one decade and it is also the longest.

The worm Loa Loa was originally found in Africa and has now reached Asia. The mangrove fly or deer fly is believed to be the carrier of this worm. The eggs of the worm enter the human body through small wounds inflicted by the fly. The death of the worm inside the body could be fatal as it could contaminate the blood. The disease is known as microfilariasis or Loa Loa infestation (Loiasis).

The video portal www.indiavideo.org and the Indian language portal www.oneindia.in are taking the video to the world. According to Mr. M.R. Hari, Executive Editor of India Video, the process recorded by Dr. Ashley fetched 2 million views on Facebook in three days and this persuaded them to make a short movie with supporting information to make it useful. Loa Loa disease could be a major health problem in future and hence an awareness campaign is the need of the hour. ‘We take up that mission now’ says

Mr. Sriram Hebbar, CEO of One India.

Via EPR Network
More Healthcare press releases

Holistic Health Breakthrough Can End Sickness Now

Holistic health and wellness expert Steve Carney has relaunched his health website, EndSicknessNow.com. The newly revamped site has also reached a milestone with its 75th article. The site’s mission is to help readers and clients reach optimum health and longevity, a mission inspired by Steve’s own battles with serious health and life obstacles.

“After a terrible childhood illness, I spent 20 years researching health, nutrition and disease prevention and treatment. I use a unique blend of consulting, support and encouragement to help each client achieve their health goals. Common health problems, such as high blood pressure, high cholesterol, excess weight, pain and inflammation often improve in a few weeks. Client’s enjoy more energy, stamina, and better sleep,” Steve explained.

End Sickness Now is an expert source for optimum health and disease prevention. Steve provides the latest research and newest breakthrough methods for easy weight loss, preventing and treating health conditions, and improving mood. The site also helps to expose numerous nutrition, health and disease myths perpetrated by the medical industry and the media.

“The constant flow of myths and misinformation creates confusion. Decades of nutrition and medical myths have harmed people’s health, along with their chances to live a longer life,” Carney stated.

Steve is a Certified Nutrition and Fitness expert, and Professional Life Coach. For those who wish to take their first steps toward optimum health and wellness, contact Steve for more information about a free, 30-minute phone assessment.

Via EPR Network
More Healthcare press releases

In support of World Diabetes Day, Harvey Norman’s Connected Fitness team research reveals that 280 Australians develop diabetes every day

In support of World Diabetes Day (14 November), Harvey Norman’s Connected Fitness team carried out a detailed research project to uncover the extent of Australia’s type 2 diabetes problem. The worrying results indicate that an estimated 1.7 million Australians suffer from type 2 diabetes today, with up to half of these cases currently undiagnosed. Reports from The World Health Organisation indicate that the total number of diabetic Australians is expected to increase to 3.3 million by 2031, creating a healthcare timebomb for the country. An infographic to visually represent the results has been specially commissioned and can be found on the Harvey Norman website.

Diabetes can significantly impact the quality of life and life expectancy of its sufferers. Some of the potential health complications caused by the disease include kidney damage, heart disease and stroke, loss of vision, and foot ulcers leading to limb amputation. The long term impacts on the life of the sufferer, and on healthcare costs for the country, are significant. However, it is known that up to around 60% of cases of type 2 diabetescould be prevented.

Key steps that can be taken to help prevent the development of this killer disease include eating a healthy diet, cutting out tobacco, keeping alcohol consumption within sensible limits and taking regular exercise. Walking, running and cycling are all great forms of exercise that enable people to work at their own pace and can easily be carried out in the home using treadmills and exercise bikes. Harvey Norman’s Connected Fitness team are on hand to provide help and advice on suitable fitness equipment and tools that can make it easy for people to increase their levels of activity and monitor their progress.

Harvey Norman’s Daniel Hosford, says: “World Diabetes Day should be an important date in everyone’s diary. Harvey Norman understands the importance of following a healthy lifestyle in order to protect against this debilitating disease and we’d like to do our bit to support the aims of the day. Our Connected Fitness team are happy to help our customers find the right equipment to help them take part in a healthy level of exercise, and our range is also available to purchase online for those customers who don’t have a store nearby. ”

Via EPR Network
More Healthcare press releases

1st September Marks The Start Of PCOS Awareness Month – And Hope For The 11% of Women Struggling With This Illness

Polycystic Ovary Syndrome (PCOS) Afflicts More Than 1 in 10 Women, causing obesity, infertility, increased miscarriage rates, adult acne, increased risk of heart disease, cancer and diabetes, and more. September marks a campaign to increase awareness of this common, misunderstood and potentially debilitating illness.

Women suffering from Polycystic Ovary Syndrome – a complex disorder of the endocrine system affecting 11% of women, according to a report from The Adelaide University – often find themselves desperately seeking relief from their myriad symptoms. Research shows that 9 in 10 women with PCOS consulted more than one health professional prior to their diagnosis, half took more than six months to receive a confirmed diagnosis and 4 in 10 were very dissatisfied with how they were informed about their illness.

According to the Robinson Institute “little information is given about lifestyle management or complications of PCOS even though 57% of women were confident their lifestyle management will improve their condition.” Lifestyle management is also what the latest research shows is ‘the best medicine’, and is the foundation of Dr. Rebecca Harwin’s new, comprehensive book ‘Conquer Your PCOS Naturally’.

Conquer Your PCOS Naturally – A New Book Offers A New Approach Typical treatment protocols for PCOS include a whole host of medications. From birth control pills and insulin-sensitizing medications to ovulation induction, anti-androgen medicines and topical medications, many of these conventional treatment paths can prove both ineffective and even toxic to the body.

In a desperate search for a better way, Dr. Rebecca Harwin slowly and systematically developed a cutting edge, natural approach to PCOS relief – a method she’s now compiled into an exhaustive treatment plan online and in her new book, ‘Conquer Your PCOS Naturally’.

“I won my battle against PCOS and I did it without the invasive treatments, toxic chemicals and ineffective interventions that pharmaceutical medicine has to offer. I lost approximately 20kg, and have kept it off. My period returned, and I remember exactly where I was the first time I ovulated. I no longer suffer from acne, mood swings, hot flushes, my energy levels are balanced, and my excessive hair has reduced.”

Dr. Harwin says “I knew many other women were suffering just as I had done and I also knew there was very limited accurate information available. I realized I had a responsibility to get this powerful information into the hands, minds and hearts of other women with PCOS. My book ‘Conquer Your PCOS Naturally’ is dedicated to helping women regain their health, boost their fertility, restore their period, lose excessive weight, and live a PCOS free life,” she said.

“Life-Changing”, “A Must Read For Anyone With PCOS”, “A Definitive Guide For Treatment”

The ‘Conquer Your PCOS Naturally’ approach is already enjoying a steady stream of accolades and affirmations from PCOS patients and medical professionals across the globe. According to Stacy Miller of Raleigh, North Carolina, this book has been“life changing” and after feeling “lost in a sea of information” following her diagnosis a year earlier, Miller found that reading the book armed her with the information she needed to reduce her disease risk and improve her fertility. “I feel now that I have the power to control my body, instead of continuing to let my body control me,” she said. Dana Adams, a PCOS sufferer and recent convert to the natural treatment path, agreed and pointed out that ‘Conquer Your PCOS Naturally’ is the first thing she’s read on the subject that didn’t leave her feeling mystified. “One can certainly mine the internet for information, but be warned, you will be overwhelmed with an astounding amount of recommendations of supplements, medications, therapies and the like. While there are some books out there that address the issue of PCOS, Dr. Harwin [looks] at your health and wellness as a whole, giving excellent advice on nutrition, stress management, food toxicity, supplements, exercise, and the holy grail for those of us trying to conceive, fertility. [It’s] one of the best books I have read on the subject.”

Dr. Joel Fugleberg, himself a proponent of natural treatment alternatives for PCOS sufferers, called the book not only a must read for PCOS sufferers, but also for the “health care provider looking to broaden their own understanding of this condition.” And Dr. Michael Elstein of the Eternal Health Medical Center in Sydney, Australia, agreed by commenting, “I love this book’s clarity and precision. This is a book not only for the layperson suffering from this disorder but also for the professional who wants a definitive guide for treating it.” Elstein also added, “What I love about Dr. Rebecca Harwin’s book is that it is a simple easy to read journey through all the natural means of attacking what is arguably the number one metabolic and hormonal disaster that is compromising the lives of so many women.”

With September’s PCOS Awareness Month and Dr. Harwin’s tireless dedication to raising the awareness of this common, potentially debilitating, syndrome, there is hope of recovery – and a healthy life – for women afflicted with PCOS.

Via EPR Network
More Healthcare press releases

Chris Smith, The Diabetic Chef Joins “Living Well” Diabetes Eduaction Cruise Hosted by Diabetes Daily Post (DDP)

Novi-based Diabetes Daily Post announces on June 29, 2012 that it has join hands with Chris Smith to educate diabetes patients on nutrition, diet, and diabetes cooking on Royal Caribbean Cruise which sails on January 7, 2013 for a 6 day Caribbean cruise. Other participants are Jorge Prada, MD, an Educator and Diabetes Researcher, Susan Sloane Pharmacist and Certified Diabetes Educator, a member of American Diabetes Association board of director and Charles Liu, Clinical Pharmacist with special interest in Type 2 Diabetes. With Chris Smith’s participatiion, DDP’s education program lands itself as one the most comprehensive and dynamic diabetes education program offered in the North America. The participants will receive a broad and comprehensive education including a diabetes-exercise session and onboard two-mile fun walk for diabetes to raise funds for the American Diabetes Association and go home with usable recipes and cooking methods to control their diabetes better.

“Diabetes is a cause for many other metabolic diseases such as heart and vascular diseases and stroke. Complications include loss of eye sight, kidney failure and amputation. Recent study showed a 62% reduction in diabetes-related health care costs if a comprehensive interdisciplinary diabetes education is implemented. Diet control is one of the most important facets in controlling diabetes and this is often neglected or ignored. We are very fortunate to have Chirs onboard to drive home on this point. Chris is known as one of the most caring and talented chef. He educates and motivates: he is completely at home with the subject of type 1 diabetes and type 2 diabetes. His passion comes from being a diabetic patient himself.” says Charles Liu R.Ph, MBA, DDP’s Cruise Education Coordinator and spokesman.

The Diabetes Daily Post a/k/a/ www.diabetesdailypost.com based in Novi, Michigan was created in 2011 to educate, enrich, and expand the knowledge of Diabetes. Its goal is to keep you informed about the latest news and drug innovations, provide health tools for diabetes management, motivate with triumph personal stories and talk about key opinion leaders who have worked on the elusive cure for Diabetes. The Diabetes Daily Post offers its “Living Well” Diabetes Education program both on cruises and in major cities.

Chef Chris is a Certified Executive Chef with over 20 years experience in the culinary field. With his focus on healthy cuisine, Chef Chris is an authority on diabetic nutrition and food preparation. He has been featured in TIME Magazine, USA Today, CNN, Web MD, Southern Living magazine. National television appearances include “DLIFE” and “Taking Control of Your Diabetes”. Chris is Novo Nordisk“Diabetes Academy” National tour speaking to both public and corporate audiences on the importance of cooking healthy and maintaining a healthy lifestyle. Chef Chris’s cookbook: The Diabetic Chef’s Year Round Cookbook along with Cooking with The Diabetic Chef, are published by The American Diabetes Association. Both cookbooks provide simple tips, cooking techniques and a wide range of easy to prepare recipes the whole family will enjoy!

If you’d like more information about this topic, please consult
www.diabetesdailypost.com Search cruise or click
http://diabetesdailypost.com/type-2-diabetes-travel-tips-how-to-book-a-cabin/

Via EPR Network
More Healthcare press releases

New York State Department of Health (NYSDOH) Cited for Non-Assistance to a New York Community in 9/11 Crisis

Charges of non-assistance to a New York community, post 9/11, in a context of bias and discrimination, were filed with the U.S. Health and Human Services (HHS), the Federal Emergency Management Administration (FEMA), and the New York State Division of Human Rights (NYSDHR).

According to the Verified Complaints, the New York State Department of Health (NYSDOH) ignored repeated requests to assist in the medical and mental health care of French-American residents of New York, and of French tourists trapped by the 9/11 cataclysm.

As official coordinator for the French consular 9/11 crisis task force, Gérard Sunnen, MD, a U.S. veteran and dual national, reported that many individuals were severely distraught and maximally stressed by the 9/11 catastrophe and needed acute and chronic support services. He pointed out that French president Jacques Chirac was the first president of a foreign nation to come to New York after 9/11, offering his nation’s condolences and assistance. After his visit, he promptly dispatched French senator Monique Cerisier-ben Guiga to New York to oversee consular humanitarian actions.

“The prejudicial actions of the NYSDOH then reached new heights in the era offreedom fries” as part of a pattern and in a spirit of retribution for France’s non-participation in the Iraq conflict. Curiously, nowhere did it ever reach the intensity of New York,” reports Dr. Sunnen, “please recall the well-publicized incidents of wine bottles vindictively smashed in the streets, the eggs thrown at the façade of the Consulate of France, and the inflammatory headlines in the New York tabloids during those times. Because of coordinated boycotts, many French-owned businesses failed in New York, creating widespread mental health calamities.”

“Consequences of NYSDOH’s usage of its powers traveled far beyond New York,” said Dr. Sunnen, adding, “We were working with our Egyptian colleagues on two clinical studies, under the auspices of the University of Cairo and the Egyptian Ministry of Health. Both studies aimed at major public health issues in the Middle East and in the U.S., one regarding hepatitis C in Egypt, where the hepatitis C prevalence is by far the highest in the world, and the other on diabetic skin ulcers, a major cause of lower leg amputations worldwide. “

“Due to NYSDOH’s interference, the research contracts fell through and the studies were abandoned.” Information on the impedance to these international medical research initiatives can be found on the Internet. Legislative attempts designed to curb NYSDOH’s oft-reported undemocratic practices were all vetoed by Governor George E. Pataki in 2004.

Dr. Sunnen concluded, “In countering today’s tendency for international polarizations, friends and allies need to solidify their ties and cooperative efforts, and there may be nowhere better to start than with actively nurturing medical fellowship and goodwill.”

Via EPR Network
More Healthcare press releases

A Dream Team for HIV Cure Research

This Sunday will mark the 30th anniversary of the first reports of AIDS in the United States. There is still a long road ahead toward eradicating HIV, but a “dream team for HIV reservoirs cure” has been created since 2003 with this objective.

While the HIV pandemic is still growing, with more than 7,100 daily new cases of infection, there is evidence that antiretroviral therapy costs could treble over the next 20 years.

Today there are more than 30 drugs approved to treat HIV, and while they cannot cure it, they can keep the virus suppressed to undetectable levels in blood. But HIV persists dormant in some “reservoir” and each time antiretroviral therapy is stopped, the infection rekindles. Lifelong therapy is therefore mandatory but brings problems of compliance, resistance, toxicity and cost.

These reservoirs were first described in 1997 and 5 years later Alain Lafeuillade, a French Doctor involved in HIV research, considered that it would be the challenge of the 21st Century. He consequently founded a working group uniting researchers from all over the world that first met in December 2003. This first “HIV Reservoirs, Persistence and Eradication Strategies Workshop” welcomed around 130 scientists actively involved in the field. “At that time we were seen as utopists, Doctor Lafeuillade said, and quite ignored by funding agencies and pharmaceutical companies”.

But minds greatly changed in the following years and in 2009, when the “dream team” met for the 4th time, the workshop was officially supported by the NIH (National Institutes of Health) and the ANRS (French Agency for AIDS Research). In between 2 workshops, the group of scientists are in touch via a specialized website portal they also have created.

“At the end of this year we will reconvene, Doctor Lafeuillade added, and be more than 200 scientists working on HIV cure”. The program of this 5th workshop goes from in vitro models of HIV persistence to HIV eradication clinical trials. “Participants will be able to define a clear road map for HIV cure research with a precise agenda”, Doctor Lafeuillade emphasized.

Via EPR Network
More Healthcare press releases

New Online Resource for Insulin Dependent Diabetics

Insulin dependent diabetics now have a new online resource designed specifically for them. The resource, the LongActingInsulin.com blog, scours the web for news and views of interest to both type 1 and type 2 diabetics to provide them with a “one stop-shop” for advice, entertainment and information.

“People are busy,” says the new blog’s editor, Lynn Woods, “They don’t have time to surf the web after work to see what’s interesting or important in the world of diabetes research, so we do it for them. Some of our blog posts are entertaining, most are educational, and many contain valuable up-to-the-minute information on diabetes.”

Woods describes the new blog, which launched in January and focuses on users of long acting insulin, as “informal”. “We try to approach diabetes from a positive perspective. We believe that people can not only cope with diabetes, they can thrive with it.”

A quick look through the blog showcases its diversity: an article about diabetes-sniffing dogs that warn their owners when their blood sugar gets low, FAQs about insulin pumps, tips on giving insulin injections to your cat, a diabetic-friendly lemon cheesecake recipe, stories about celebrities with diabetes, a prescription coupon offering $10 savings on Lantus SoloSTAR long acting insulin, and a wealth of current information on diabetes research and diabetes medication.

Unexpectedly, the article Kudzu Used as Diabetes Medication in Chinese Medicine has attracted the most readers by far, says Woods. Other popular diabetes blog articles involve recent developments in non-invasive blood glucose monitors and super-long-acting insulin, and advice on giving insulin injections to cats.

Diabetes affects almost 26 million Americans, over 8% of the population. Of those 26 million, an estimated 7 million remain undiagnosed. Diabetes is an incurable and progressive disease with serious complications, and is the seventh leading cause of death in the United States.

Via EPR Network
More Healthcare press releases

New Report on Fighting Chronic Disease Examines the Importance of Non-Communicable Diseases in Global Health Care

In the first of a series of new reports, a coalition of pharmaceutical industry trade organizations outlines the serious burden that chronic diseases place on patients and global health care systems.“Fighting Chronic Disease: Importance of Non-communicable Diseases” is the first of four reports that look at this growing issue for patients and health care systems around the world.

The report was compiled by the European Federation of the Pharmaceutical Industries and Associations, the International Federation of Pharmaceutical Manufacturers & Associations, the Japan Pharmaceutical Manufacturers Association, and the Pharmaceutical Researchers and Manufacturers Association. Together, these organizations highlight the powerful role that public-private partnerships can play in mitigating the burden of chronic disease. Non-communicable diseases like stroke, heart disease, diabetes, and cancers can often strain global health care resources, and targeting the main risk factors of these conditions can significantly reduce the burden of these diseases worldwide.

Most NCDs are preventable because they are caused by modifiable risk factors, which include poor diet, lack of physical activity and tobacco use. Every year, more than 5 million people die because of direct tobacco use and 2.8 million die from being overweight or obese. High cholesterol accounts for 2.6 million deaths and 7.5 million die because of elevated blood pressure. Individually, chronic disease lowers quality of life for those affected, causes premature deaths and negatively impacts the economic solvency of families, communities and nations. Interventions that focus on better diet, increased physical activity and access to vaccines have been proven to decrease the incidence of chronic disease and improve quality of life.

The pharmaceutical industry has long recognized the economic and social burden of non-communicable diseases (NCDs) and has been working with governments, health care providers, patients groups and other stakeholders as an active solution partner in lessening this burden. The industry promotes and supports health prevention and promotion strategies and patient-centered approaches to managing chronic conditions and their risk factors. At the same time the global biopharmaceutical industry leads the search for new cures and the research and development of new medicines to treat or prevent non-communicable diseases. There are currently thousands of medicines either in clinical trials or awaiting approval to treat NCDs. The great challenge in preventing and controlling NCDs on a global scale is finding patient-centered solutions that reduce the burden on global health care services by promoting individual healthy lifestyles.

The R&D-based pharmaceutical industry works to improve the health and quality of life of all patients, and is committed to continuing partnerships that tackle these complex issues including extensive investment in R&D programs dedicated to the development of new NCD preventative and treatment products. Both prevention and treatment play an important role in addressing the problem of non-communicable diseases.

The full report is available at
http://globalhealthprogress.org/mediacenter/index.php/new-report-examines…

Via EPR Network
More Healthcare press releases

Global Health Progress Releases Non-Communicable Diseases Partnerships and Programs List

Global Health Progress compiled a list of non-communicable disease treatment programs from around the world, highlighting partnerships to address cancer treatment, diabetes care, epilepsy programs and more. The programs, sponsored by leading companies like Astra Zeneca, Abbott, Novo Nordisk, and Bayer Healthcare, aim to increase awareness of non-communicable diseases in the developing world.

“Our goal in creating this list is to bring awareness to these companies who work so hard at fighting diseases in developing countries,” explains Mark Grayson, Vice President of Communications and Public Affairs at PhRMA and key developer in the Global Health Progress initiative. “Non-communicable diseases are the leading killer in many of these countries, and without the help of these programs they would continue to increase.”

Global Health Progress works with partner groups to encourage and sustain funding for the research and development of healthcare in developing nations. Improving health care systems and access to medicines, especially in the developing world, requires multifaceted approaches and solutions. Research-based biopharmaceutical companies are active partners in some of the largest and boldest health initiatives that explore new and effective ways to provide treatment, care and education to millions of people in developing countries.

Read the full list of non-communicable disease treatment programs here:
http://globalhealthprogress.org/mediacenter/wp-content/uploads/NCD-Health-Partnerships-and-Programs_Worldwide-05-02-11.pdf.

Via EPR Network
More Healthcare press releases

From Universal HIV Testing to HIV Cure

People involved in the fight against HIV/AIDS will gather in Marseille, France, May 23-25, 2012 for an international AIDS Conference under the theme: ‘From Universal HIV Testing to HIV Cure’.

The ISHEID (International Symposium on HIV & Emerging Infectious Diseases) is a major scientific event attracting doctors, biologists, researchers, patients’ representatives and policy makers from all around the world. Its next edition, to be held just more than one year ahead, will focus on recent developments against this pandemic.

Despite major advances in antiretroviral therapy, HIV still infects daily 2,000 new individuals and kills 2 millions each year. Current treatments are life-long with problems of compliance, resistance, toxicity, access, and cost.

‘There are advances both in the area of prevention, testing and potential cure’ told Alain Lafeuillade, a French Doctor involved in the organization of the conference. ‘Our driving force is to draw to the conference the best experts in the world for each program theme’. Antiretroviral treatment as prevention (or pre-exposure prophylaxis) will be debated with the pros and cons. Human rights and access to HIV care will be the focus of en entire session. Current issues in antiretroviral therapy management will be discussed during 2 sessions. Finally, the best American experts in the field of HIV reservoirs and eradication research will present their latest discoveries in the search for a cure.

The international Steering Committee will actively build a program the most exciting possible in the forthcoming months. Meanwhile, interviews of renowned experts are regularly published on the meeting website: http://www.isheid.com/en/committees/interview.html

Via EPR Network
More Healthcare press releases

Medical Innovation Protection Stressed in EU-India Free Trade Agreement Talks

The Financial Express published an article on the Free Trade Agreement (FTA) talks that continue between the European Union (EU) and India. One of the most discussed and disagreed upon parts of the proposed FTA involves the need for protecting the intellectual property of pharmaceutical companies in order to promote medical innovation and investment in the development of new medicines and research. This disagreement about whether data exclusivity in the pharmaceutical sector should be included has resulted in the delay of finalizing the FTA.

Pharmaceutical companies rely on data exclusivity to protect the investment made in developing the medication that is used throughout the world. Millions of dollars are spent on clinical trials to prove the safety and effectiveness of these drugs. These exclusive rights prevent competitors from obtaining marketing licenses for lower cost versions of these drugs.

Global Health Progress (GHP) is committed to being part of the effort to create a sustainable health care system that includes improving access to health care and continuing medical innovation and progress for all people. While the pharma industry is divided on the issue, GHP supports efforts to improve regulations protecting pharmaceutical companies’ intellectual property. Without this protection, the funding of studies that bring these medications to market could suffer.

Improving health care systems and access to medicines, especially in the developing world, requires multifaceted approaches and solutions. Research-based biopharmaceutical companies are active partners in some of the largest and boldest health initiatives that explore new and effective ways to provide treatment, care and education to millions of people in developing countries.

About Global Health Progress:
Global Health Progress also supports efforts to raise awareness and mobilize resources to address health challenges in the developing world by bringing local leaders together with international health experts, policymakers, donor governments, and the private sector.

www.globalhealthprogress.org;

twitter.com/globalhealth;

facebook.com/pages/Global-Health-Progress/124850684219049;

linkedin.com/groups?home=&gid=2972068

Via EPR Network
More Healthcare press releases

Global Health Progress Amplifies Report Calling for Funding Products to Fight Neglected Tropical Diseases

The third-annual Global Funding of Innovation for Neglected Diseases (G-FINDER) survey was released last week revealing both good and bad news for the funding of neglected diseases in the developing world. In a press release issued by Policy Cures, an independent group providing research and analysis for those involved in the creation of new pharmaceuticals for neglected diseases, the group reveals that while funding for neglected diseases has increased, funding for new products has decreased.

Funders appear to be focusing more of their money toward traditional basic research. This shift has caused a $50 million drop in funding for Product Development Partnerships (PDP), non-profit organizations that partner with external organizations to drive product development for neglected diseases, including neglected tropical diseases.

Report author Dr Mary Moran, Director of Policy Cures warns funders not to “take their eyes off the ball” in the press release, stating that while the increase in funding is encouraging it is important that the funds are spent wisely.

Global Health Progress has worked with partner groups to encourage and sustain funding for the research and development of new products. The innovative research and development (R&D) of new drugs and vaccines is a critical component of improving health care and combating epidemics of neglected tropical diseases in developing countries. There are no vaccines or cures for some widespread and life threatening diseases such as malaria, while existing treatments for diseases such as tuberculosis are becoming less effective due to drug resistance.

Read the full press release from Policy Cures here:
http://globalhealthprogress.org/mediacenter/wp-content/uploads/G-FINDER_Year_3_media_release.pdf,
or read the G-FINDER report on the Policy Cures website:
http://www.policycures.org/downloads/g-finder_2010.pdf.

Via EPR Network
More Healthcare press releases

Global Health Progress Encourages Global Partnerships on Access to Health Care

Starting this month, members of Congress will be looking closely at U.S. spending as they work with the White House to build the 2012 budget. One area that has come under increased scrutiny is U.S. spending on global health programs. Several groups last week announced a petition (http://www.supportglobalhealth.org/) seeking support for global health spending through the United States Global Health Initiative. Many fear that even flat spending in this area could jeopardize important programs in vaccine research and treatment.

News like this highlights the important role that public-private partnerships play in supporting access to global health care. The Global Health Progress initiative seeks to bring research-based biopharmaceutical companies and global health leaders together to improve access to medicine and health care in the developing world. We are committed to being part of the effort to create a sustainable health care system that includes improving access to health care and continuing medical innovation and progress for all people.

Research-based biopharmaceutical companies and their partners around the world are working to implement sustainable solutions and strengthen the health care delivery systems so they can meet tomorrow’s challenges. Millions of people lack access to essential medicines due to factors including incomplete delivery systems, lack of training for health personnel, lack of infrastructure and the cost of treatments. We must address the underlying barriers to health care, such as weak and fragmented health systems, limited health care personnel and inadequate resources for scaling up proven solutions. The innovative research and development (R&D) of new drugs and vaccines is a critical component of improving health care and combating epidemics in developing countries.

Through meaningful public-private partnerships with others in the field, including policymakers in the developed and developing world, multi-lateral institutions, non-governmental organizations, and academia we can help shape sustainable solutions that improve the health of all people.

To stay informed on the latest news about global investment in pharmaceutical R&D and improving access to medicines, sign up to receive special alerts and newsletters. You can also spread the word about the efforts of the Global Health Progress initiative and keep others informed about how we’re affecting change around the world, or share your story about how you or someone you know is working to promote global health.

Via EPR Network
More Healthcare press releases